Advances and prospects in tumor infiltrating lymphocyte therapy

Advances and prospects in tumor infiltrating lymphocyte therapy

Abstract Tumor-infiltrating lymphocyte (TIL) therapy in adoptive T-cell therapy (ACT) has already caused durable regression in a variety of cancer types due to T-cell persistence, clinical activity, and duration of objective response and safety. TILs are composed of polyclonal effector T-cells speci...

Full description

Saved in:
Bibliographic Details
Main Authors: Xu Qiu, Shengjun Li, Tianyu Fan, Yue Zhang, Bin Wang, Bei Zhang, Mingzhe Zhang, Li Zhang
Format: Article
Language:English
Published: Springer 2024-11-01
Series:Discover Oncology
Subjects:
Tumor infiltrating lymphocyte (TIL)
T-cells
Adoptive cell therapy (ACT)
Immunotherapy
Tumor treatment
Online Access:https://doi.org/10.1007/s12672-024-01410-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items